A Systematic Review of Lifestyle Modification in Adults with Non-Alcoholic Fatty Liver Disease
Poster Apr 04, 2012
C. Thoma, C. P. Day and M. I. Trenell, Newcastle University
Non-alcoholic fatty liver disease is an independent risk factor for type 2 diabetes and cardiovascular disease that affects about 30% of the adult population. There is no approved pharmacotherapy, thus lifestyle modification is broadly advocated as a treatment. Prior to this review, there was no systematic assessment of the evidence base for making lifestyle change recommendation in this group of patients.
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluationPoster
These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.READ MORE
A luminescent solar concentrator-based photomicroreactor for energy efficient continuous-flow photocatalysisPoster
The Luminescent Solar ConcentratorPhotomicroreactor
(LSC-PM) is an innovative device
for solar-powered continuous-flow photochemistry.
Comments | 0 ADD COMMENT
Orphan Drugs and Rare Diseases Global Congress 2017 USA
Sep 12 - Sep 14, 2017